Pharmaceutical for prevention of bleomycin-induced pulmonary fibrosis
AssigneeUniversity of South Carolina
InventorsMICHAEL WYATT, CHLOE E. LEBEGUE
Life of this patent
Estimating the term…
Abstract
Disclosed is an inhalable pharmaceutical composition that includes bleomycin hydrolase. The inhalable pharmaceutical composition can encompass a dry inhalable powder, aerosol, or a liquid-based composition for nebulization. Also disclosed are methods an for forming an inhalable pharmaceutical comprising bleomycin hydrolase. Disclosed compositions can be used in prevention of bleomycin-induced pulmonary fibrosis.
Claims20
A pharmaceutical composition comprising bleomycin hydrolase, wherein the pharmaceutical composition is an inhalable pharmaceutical composition.
A method for forming a pharmaceutical composition, the method comprising incorporating a bleomycin hydrolase in a particulate or droplets, wherein the particulates or droplets are inhalable.
Dependencies are inferred from the claim text.